<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04295473</url>
  </required_header>
  <id_info>
    <org_study_id>2020002</org_study_id>
    <nct_id>NCT04295473</nct_id>
  </id_info>
  <brief_title>Reduced Port Laparoscopic Gastrectomy for Gastric Cancer</brief_title>
  <official_title>Comparison the Short and Long-term Outcome of Patients With Gastric Cancer Who Underwent Reduced Port Laparoscopic Gastrectomy With Patients Underwent Traditional Laparoscopic Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanchong Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanchong Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of
      reduced port laparoscopic gastrectomy has not been systematically evaluated. The
      investigators sought to compare the short and long-term outcome of patients with gastric
      cancer who underwent reduced port gastrectomy with patients underwent traditional
      laparoscopic gastrectomy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of
      reduced port laparoscopic gastrectomy has not been systematically evaluated. The
      investigators designed a comparative study, which sought to compare the short and long-term
      outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients
      underwent traditional laparoscopic gastrectomy. The short-term outcome include surgical
      complications, postoperative morbidity, postoperative nutrition. The long-term outcome mainly
      include long-term survival.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>5-year survival rate</measure>
    <time_frame>5 years</time_frame>
    <description>Longterm survival for patients with gastrectomy after reduced port laparoscopic gastrectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3-year survival rate</measure>
    <time_frame>3 years</time_frame>
    <description>Survival rate for patients with gastrectomy after reduced port laparoscopic gastrectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative morbidity rate</measure>
    <time_frame>6 months</time_frame>
    <description>Postoperative morbidity rate for patients with gastrectomy after reduced port laparoscopic gastrectomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malnutrition rate</measure>
    <time_frame>6 months</time_frame>
    <description>Malnutrition rate for patients with gastrectomy after reduced port</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life in PGSAS-45 scale</measure>
    <time_frame>12 months</time_frame>
    <description>The quality of life were assessed using PGSAS-45 scale for patients with gastrectomy after reduced port laparoscopic gastrectomy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Laparoscopic</condition>
  <condition>Gastrectomy</condition>
  <arm_group>
    <arm_group_label>Reduced port laparoscopic gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The definition of reduced port laparoscopic gastrectomy was 1-3 ports used in laparoscopic gastrectomy for gastric cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard laparoscopic gastrectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>5 ports were used in standard laparoscopic gastrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reduced port laparoscopic gastrectomy</intervention_name>
    <description>The ports were reduced in the surgery of intervention arm.</description>
    <arm_group_label>Reduced port laparoscopic gastrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.

          2. Eastern Cooperative Oncology Group performance status of 0 or 1.

          3. Adequate organ function.

        Exclusion Criteria:

          1. Patients had distant metastasis.

          2. oesophageal invasion of more than 3 cm.

          3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.

          4. Previous chemotherapy or radiation therapy for any other malignancies.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunhong Tian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanchong Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yunhong Tian, MD</last_name>
    <phone>+86-13508087719</phone>
    <email>drtianyunhong@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yunhong Tian</name>
      <address>
        <city>Nanchong</city>
        <state>Sichuan</state>
        <zip>637000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunhong Tian, Doctor</last_name>
      <phone>+8613508087719</phone>
      <email>drtianyunhong@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 29, 2020</study_first_submitted>
  <study_first_submitted_qc>March 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanchong Central Hospital</investigator_affiliation>
    <investigator_full_name>Yunhong Tian</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

